DocMorris AG

BATS-CHIXE:DOCMZ Stock Report

Market Cap: CHF 381.0m

DocMorris Valuation

Is DOCMZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DOCMZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DOCMZ (CHF29.42) is trading below our estimate of fair value (CHF268.88)

Significantly Below Fair Value: DOCMZ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DOCMZ?

Key metric: As DOCMZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for DOCMZ. This is calculated by dividing DOCMZ's market cap by their current revenue.
What is DOCMZ's PS Ratio?
PS Ratio0.4x
SalesCHF 1.00b
Market CapCHF 380.97m

Price to Sales Ratio vs Peers

How does DOCMZ's PS Ratio compare to its peers?

The above table shows the PS ratio for DOCMZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.8x
KITW Kitwave Group
0.4x12.0%UK£256.6m
CBOX Cake Box Holdings
2x8.1%UK£77.0m
WINE Naked Wines
0.1x-8.6%UK£39.2m
OCDO Ocado Group
0.8x8.4%UK£2.5b
DOCMZ DocMorris
0.4x16.3%CHF 381.0m

Price-To-Sales vs Peers: DOCMZ is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (0.8x).

Price to Sales Ratio vs Industry

How does DOCMZ's PS Ratio compare vs other companies in the European Consumer Retailing Industry?

10 CompaniesPrice / SalesEstimated GrowthMarket Cap
No. of Companies13PS00.40.81.21.62+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: DOCMZ is expensive based on its Price-To-Sales Ratio (0.4x) compared to the European Consumer Retailing industry average (0.3x).

Price to Sales Ratio vs Fair Ratio

What is DOCMZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DOCMZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ratio0.6x

Price-To-Sales vs Fair Ratio: DOCMZ is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DOCMZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 29.42
CHF 52.33
+77.9%
33.6%CHF 90.00CHF 25.00n/a12
Nov ’25CHF 34.82
CHF 52.50
+50.8%
33.3%CHF 90.00CHF 25.00n/a12
Oct ’25CHF 36.98
CHF 65.92
+78.2%
40.0%CHF 125.00CHF 27.00n/a12
Sep ’25CHF 38.72
CHF 78.00
+101.4%
35.5%CHF 125.00CHF 27.00n/a12
Aug ’25CHF 44.46
CHF 88.50
+99.1%
28.2%CHF 125.00CHF 29.00n/a12
Jul ’25CHF 52.90
CHF 98.58
+86.4%
26.3%CHF 130.00CHF 29.00n/a12
Jun ’25CHF 67.15
CHF 99.24
+47.8%
25.5%CHF 130.00CHF 31.90n/a12
May ’25CHF 82.90
CHF 99.24
+19.7%
25.5%CHF 130.00CHF 31.90n/a12
Apr ’25CHF 90.85
CHF 88.91
-2.1%
26.5%CHF 115.00CHF 29.00n/a11
Mar ’25CHF 78.05
CHF 77.92
-0.2%
28.8%CHF 105.00CHF 29.00n/a12
Feb ’25CHF 79.05
CHF 77.92
-1.4%
28.8%CHF 105.00CHF 29.00n/a12
Jan ’25CHF 73.45
CHF 69.00
-6.1%
31.9%CHF 102.00CHF 29.00n/a12
Dec ’24CHF 59.60
CHF 62.27
+4.5%
31.4%CHF 95.00CHF 29.00n/a11
Nov ’24CHF 37.54
CHF 62.27
+65.9%
31.4%CHF 95.00CHF 29.00CHF 34.8211
Oct ’24CHF 51.15
CHF 64.86
+26.8%
30.1%CHF 95.00CHF 29.50CHF 36.9811
Sep ’24CHF 59.40
CHF 62.38
+5.0%
32.8%CHF 95.00CHF 29.50CHF 38.7212
Aug ’24CHF 53.50
CHF 52.50
-1.9%
27.0%CHF 80.00CHF 27.00CHF 44.4612
Jul ’24CHF 38.96
CHF 51.25
+31.5%
27.5%CHF 80.00CHF 27.00CHF 52.9012
Jun ’24CHF 30.62
CHF 53.08
+73.4%
23.4%CHF 80.00CHF 37.00CHF 67.1512
May ’24n/a
CHF 53.62
0%
23.1%CHF 80.00CHF 31.00CHF 82.9013
Apr ’24n/a
CHF 54.62
0%
22.7%CHF 80.00CHF 31.00CHF 90.8513
Mar ’24n/a
CHF 54.33
0%
19.3%CHF 71.00CHF 31.00CHF 78.0512
Feb ’24n/a
CHF 37.96
0%
61.4%CHF 106.00CHF 19.00CHF 79.0512
Jan ’24n/a
CHF 53.96
0%
97.9%CHF 210.00CHF 19.00CHF 73.4512
Dec ’23n/a
CHF 54.04
0%
97.7%CHF 210.00CHF 19.00CHF 59.6012
Nov ’23n/a
CHF 54.96
0%
95.2%CHF 210.00CHF 19.00CHF 37.5412

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y